Top Markets
#1 Akedo Akedo +54.88%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.11%
#4 Velvet Velvet +43.34%
#5 Black Phoenix Black Phoenix +34.52%
#6 τemplar τemplar +23.53%
#7 Cross Cross +19.33%
#8 Ribbita by Virtuals Ribbita by Virtuals +16.59%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.38%
#10 Perle Perle +15.05%
Coin of the day
Akedo Akedo
設定
言語
日本
通貨
USD
テーマ
Genomic Valley Biotech Ltd Genomic Valley Biotech Ltd

Genomic Valley Biotech Ltd

GVBL
株式のランク #38372
Genomic Valley Biotech Limited operates in horticulture business activities in... Genomic Valley Biotech Limited operates in horticulture business activities in India. The company involved in the commercial greenhouse/poly house cultivation of crops; commercial horticulture activities with aloe vera, tomato, bitter gourd, bottle gourd, brinjal, broccoli, cabbage, capsicum, carrot, cauliflower, cucumber, green chilies, onion, radish, ridge/sponge gourd, leafy vegetables, pumpkin, banana, guava, papaya, and strawberry; and commercial floriculture of flowers. It undertakes contracts for its clients for erecting greenhouses; and provides turnkey consultancy services. In addition, the company manufactures and markets bio-fertilizers; and offers farmer support apps. Further, it is involved in the operation of plant tissue culture process laboratory to produce tissue cultured plantlets. Genomic Valley Biotech Limited was incorporated in 1994 and is based in Jhajjar, India.
株価
$0.33549067
時価総額
$1.02M
変化（1日）
4.79%
変化（1年）
-28.09%
国
IN
取引 Genomic Valley Biotech Ltd (GVBL)

カテゴリー

Healthcare
Genomic Valley Biotech Ltd（GVBL）の収益
Aug 2026 時点の収益 TTM: 0
Genomic Valley Biotech Ltd の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Genomic Valley Biotech Ltd の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE